Answers are grounded in this paper and cite their sources.
Freeze-dried cheese powders provide concentrated flavor and extended shelf life, but their quality may depend on cheese type and sample morphology before drying. This study evaluated the effects of cheese type (Cheddar, Mozzarella, and enzyme-modified cheese (EMC)), pre-drying morphology (shreds, slices, and cubes), and storage/ripening time (0, 30, and 60 days) on the physicochemical properties, volatile profile, fatty acid composition, and oxidative stability of freeze-dried cheese powders. Proximate composition, water activity, free fatty acids, peroxide value, total oxidation value, and thiobarbituric acid-reactive substances were determined, while volatile compounds and fatty acids were analyzed by gas chromatography-mass spectrometry. Cheese type, morphology, and storage/ripening time significantly affected most attributes ( p < 0.05 ). All powders had high total solids (96.01–97.88%) and low water activity (0.21–0.25). Cheddar developed the most complex volatile profile, whereas EMC showed accelerated flavor development, the highest free fatty acid content (0.26–0.46%), and the highest total oxidation values (5.1–7.5). Mozzarella retained a milder volatile profile and greater oxidative stability. Cubes generally retained higher concentrations of volatile compounds, whereas shreds favored moisture removal and showed greater lipolysis and oxidation. These findings demonstrate that cheese type and pre-drying morphology can be optimized to balance flavor development, oxidative stability, and storage performance.
No takes yet. Share an insight, caveat, or question.
Manzoor et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: